Impurity Profiling of Active Pharmaceutical Ingredients (APIs)

Impurity profiling plays a critical role in ensuring the safety, efficacy, and quality of Active Pharmaceutical Ingredients (APIs). Pharmaceutical impurities may arise from starting materials, intermediates, by-products, degradation pathways, or contamination during manufacturing and storage. Regulatory bodies such as ICH, FDA, and EMA mandate strict identification, quantification, and control of these impurities to safeguard patient health. This review provides a comprehensive overview of impurity types including organic, inorganic, and residual solvents—as well as factors affecting impurity formation, such as environmental conditions, formulation processes, and functional group reactivity. Various analytical and isolation techniques used in impurity profiling, including HPLC, GC, HPTLC, CE, NMR, MS, IR spectroscopy, gravimetric analysis, and chromatographic methods, are discussed along with their applications and limitations. The significance of impurity profiling in drug development, regulatory compliance, process optimization, and stability studies is highlighted. This review emphasizes that robust impurity profiling is essential for maintaining pharmaceutical quality standards and ensuring the therapeutic reliability of drug products.